Viewing Study NCT03629132


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2026-01-02 @ 8:32 AM
Study NCT ID: NCT03629132
Status: UNKNOWN
Last Update Posted: 2018-08-14
First Post: 2018-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PRP Prevents Recurrence of Intrauterine Adhesions
Sponsor: Yanhong Deng
Organization:

Study Overview

Official Title: Platelet-rich Plasma(PRP) Prevents Recurrence of Intrauterine Adhesions
Status: UNKNOWN
Status Verified Date: 2018-08
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RPR-IUAs
Brief Summary: Effect of platelet-rich plasma (PRP) on uterine scar fibrosis, endometrial receptivity and pregnancy outcome in patients with severe intrauterine adhesions
Detailed Description: 1. Inclusion criteria: patients with intrauterine adhesions (AFS score \>9 points); age 21 to 40 years old, with fertility requirements.
2. Study design:prospective, randomized controlled cohort study, patients with intrauterine adhesions were randomized into two groups, the control group and the intervention group (intraoperative and postoperative 1 week postoperative PRP). The surgical procedures and postoperative medication regimens were the same.
3. Compare the biochemical pregnancy rate, clinical pregnancy rate, abortion rate and live birth rate after hysteroscopic resection in PRP group and control group, and explore the effect of PRP on pregnancy outcome after intrauterine adhesion.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: